Simultaneous HPLC-MS-MS Quantification of 8-iso-PGF(2alpha) and 8,12-iso-iPF(2alpha) in CSF and Brain Tissue Samples with On-line Cleanup

Overview

Journal J Chromatogr B Analyt Technol Biomed Life Sci

Publisher Elsevier

Specialties Biomedical Engineering
Chemistry

Date 2010 Jul 21

PMID 20643588

Citations 7

Authors

Magdalena Korecka

Christopher M Clark

Virginia M-Y Lee

John Q Trojanowski

Leslie M Shaw

Affiliations

Soon will be listed here.

Abstract

Quantitation of isoprostanes such as 8-iso-PGF(2alpha) and 8,12-iso-iPF(2alpha)-VI in biological fluids has been proposed as a reliable test of oxidant stress and inflammation in a variety of disorders. This paper presents a liquid chromatography method with tandem mass spectrometry detection for the simultaneous analysis of these two isoprostanes in human CSF and brain tissue samples. An API 5000 triple quadrupole instrument (AB Sciex, Foster City, CA, USA) with an APCI ion source was used in this study. Aliquots of CSF samples (0.25mL) were treated with a methanol:zinc sulfate mixture followed by on-line cleanup on an extraction column (Validated-C(18)) with 0.1% formic acid. The brain tissue samples were homogenized and lipids were extracted using Folch solution. Solid-phase extraction columns (C(18)) were used for the purification of the brain isoprostane fraction. Chromatographic separation was achieved using an analytical column (Synergi C(18) HydroRP) with 0.1% formic acid in water and a mixture of methanol:acetonitrile under isocratic conditions. The mass spectrometer was operated in the MRM scan and negative ion mode. The quadrupoles were set to detect the molecular ions [M-H](-) and high mass fragments of isoprostanes: m/z 353-->193amu (8-iso-PGF(2alpha)) and m/z 353-->115amu (8,12-iso-iPF(2alpha)-VI) and their deuterated internal standards: m/z 357-->197amu (8-iso-PGF(2alpha)-d(4)) and m/z 364-->115amu (8,12-iso-iPF(2alpha)-VI-d(11)). The lower limit of quantification was 2.5pg/mL for 8-iso-PGF(2alpha) and 5.0pg/mL for 8,12-iso-PF(2alpha)-VI for the CSF method and 10.0pg/0.1g of tissue and 30.0pg/0.1g of tissue for 8-iso-PGF(2alpha) and 8,12-iso-iPF(2alpha)-VI, respectively, for the brain tissue method. No ion suppression or enhancement of the detection of 8-isoPGF(2alpha), 8,12-isoPF(2alpha)-VI or both internal standards was found.

Citing Articles

Active Cigarette Smoking in Cognitively-Normal Elders and Probable Alzheimer's Disease is Associated with Elevated Cerebrospinal Fluid Oxidative Stress Biomarkers.

Durazzo T, Korecka M, Trojanowski J, Weiner M, O Hara R, Ashford J J Alzheimers Dis. 2016; 54(1):99-107.

PMID: 27472882 PMC: 5127393. DOI: 10.3233/JAD-160413.

Lipidomic analysis of cerebrospinal fluid by mass spectrometry-based methods.

Colsch B, Seyer A, Boudah S, Junot C J Inherit Metab Dis. 2014; 38(1):53-64.

PMID: 25488626 DOI: 10.1007/s10545-014-9798-0.

The isoprostanes--25 years later.

Milne G, Dai Q, Roberts 2nd L Biochim Biophys Acta. 2014; 1851(4):433-45.

PMID: 25449649 PMC: 5404383. DOI: 10.1016/j.bbalip.2014.10.007.

Influence of lifestyle modifications on age-related free radical injury to brain.

Peskind E, Li G, Shofer J, Millard S, Leverenz J, Yu C JAMA Neurol. 2014; 71(9):1150-4.

PMID: 25048271 PMC: 4160350. DOI: 10.1001/jamaneurol.2014.1428.

History of cigarette smoking in cognitively-normal elders is associated with elevated cerebrospinal fluid biomarkers of oxidative stress.

Durazzo T, Mattsson N, Weiner M, Korecka M, Trojanowski J, Shaw L Drug Alcohol Depend. 2014; 142:262-8.

PMID: 25037769 PMC: 4144023. DOI: 10.1016/j.drugalcdep.2014.06.030.

References

Ritov V, Kelley D, Kagan V . Derivatization of F2-isoprostanes with 1-pyrenyldiazomethane and their subsequent determination by fluorescence high-performance liquid chromatography. Anal Biochem. 2002; 311(1):10-8. DOI: 10.1016/s0003-2697(02)00392-5. View

Pratico D, Barry O, Lawson J, Adiyaman M, Hwang S, Khanapure S . IPF2alpha-I: an index of lipid peroxidation in humans. Proc Natl Acad Sci U S A. 1998; 95(7):3449-54. PMC: 19856. DOI: 10.1073/pnas.95.7.3449. View

Lawson J, Li H, Rokach J, Adiyaman M, Hwang S, Khanapure S . Identification of two major F2 isoprostanes, 8,12-iso- and 5-epi-8, 12-iso-isoprostane F2alpha-VI, in human urine. J Biol Chem. 1998; 273(45):29295-301. DOI: 10.1074/jbc.273.45.29295. View

Matuszewski B, Constanzer M, Chavez-Eng C . Matrix effect in quantitative LC/MS/MS analyses of biological fluids: a method for determination of finasteride in human plasma at picogram per milliliter concentrations. Anal Chem. 1998; 70(5):882-9. DOI: 10.1021/ac971078+. View

KING R, Bonfiglio R, Fernandez-Metzler C, Miller-Stein C, Olah T . Mechanistic investigation of ionization suppression in electrospray ionization. J Am Soc Mass Spectrom. 2000; 11(11):942-50. DOI: 10.1016/S1044-0305(00)00163-X. View

Morales C, Terry E, Zackert W, Montine T, Morrow J . Improved assay for the quantification of the major urinary metabolite of the isoprostane 15-F(2t)-Isoprostane (8-iso-PGF(2alpha)) by a stable isotope dilution mass spectrometric assay. Clin Chim Acta. 2001; 314(1-2):93-9. DOI: 10.1016/s0009-8981(01)00637-4. View

Morrow J, Roberts 2nd L . Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol. 1999; 300:3-12. DOI: 10.1016/s0076-6879(99)00106-8. View

Morrow J, Roberts L . The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease. Am J Respir Crit Care Med. 2002; 166(12 Pt 2):S25-30. DOI: 10.1164/rccm.2206011. View

Haschke M, Zhang Y, Kahle C, Klawitter J, Korecka M, Shaw L . HPLC-atmospheric pressure chemical ionization MS/MS for quantification of 15-F2t-isoprostane in human urine and plasma. Clin Chem. 2007; 53(3):489-97. DOI: 10.1373/clinchem.2006.078972. View

10.

Taylor P . Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin Biochem. 2005; 38(4):328-34. DOI: 10.1016/j.clinbiochem.2004.11.007. View

11.

Mei H, Hsieh Y, Nardo C, Xu X, Wang S, Ng K . Investigation of matrix effects in bioanalytical high-performance liquid chromatography/tandem mass spectrometric assays: application to drug discovery. Rapid Commun Mass Spectrom. 2002; 17(1):97-103. DOI: 10.1002/rcm.876. View

12.

Montine T, Montine K, McMahan W, Markesbery W, Quinn J, Morrow J . F2-isoprostanes in Alzheimer and other neurodegenerative diseases. Antioxid Redox Signal. 2005; 7(1-2):269-75. DOI: 10.1089/ars.2005.7.269. View

13.

Ohashi N, Yoshikawa M . Rapid and sensitive quantification of 8-isoprostaglandin F2alpha in human plasma and urine by liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr B Biomed Sci Appl. 2000; 746(1):17-24. DOI: 10.1016/s0378-4347(00)00201-2. View

14.

Bohnstedt K, Karlberg B, Wahlund L, Eriksdotter Jonhagen M, Basun H, Schmidt S . Determination of isoprostanes in urine samples from Alzheimer patients using porous graphitic carbon liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2003; 796(1):11-9. DOI: 10.1016/s1570-0232(03)00600-7. View

15.

Winnik W, Kitchin K . Measurement of oxidative stress parameters using liquid chromatography-tandem mass spectroscopy (LC-MS/MS). Toxicol Appl Pharmacol. 2008; 233(1):100-6. DOI: 10.1016/j.taap.2008.05.003. View

16.

Pratico D, Lawson J, Rokach J, FitzGerald G . The isoprostanes in biology and medicine. Trends Endocrinol Metab. 2001; 12(6):243-7. DOI: 10.1016/s1043-2760(01)00411-8. View

17.

Shah V, Midha K, Findlay J, HILL H, Hulse J, McGilveray I . Bioanalytical method validation--a revisit with a decade of progress. Pharm Res. 2001; 17(12):1551-7. DOI: 10.1023/a:1007669411738. View

18.

Liang Y, Wei P, Duke R, Reaven P, Harman S, Cutler R . Quantification of 8-iso-prostaglandin-F(2alpha) and 2,3-dinor-8-iso-prostaglandin-F(2alpha) in human urine using liquid chromatography-tandem mass spectrometry. Free Radic Biol Med. 2003; 34(4):409-18. DOI: 10.1016/s0891-5849(02)01018-3. View

19.

Li H, Lawson J, Reilly M, Adiyaman M, Hwang S, Rokach J . Quantitative high performance liquid chromatography/tandem mass spectrometric analysis of the four classes of F(2)-isoprostanes in human urine. Proc Natl Acad Sci U S A. 1999; 96(23):13381-6. PMC: 23956. DOI: 10.1073/pnas.96.23.13381. View

20.

Montuschi P, Ragazzoni E, Valente S, Corbo G, Mondino C, Ciappi G . Validation of 8-isoprostane and prostaglandin E(2) measurements in exhaled breath condensate. Inflamm Res. 2004; 52(12):502-7. DOI: 10.1007/s00011-003-1212-6. View